Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119589) titled 'A randomized, open label, controlled multicenter clinical study comparing the safety and efficacy of hydromorphone sustained-release tablets and hydrocodone sustained-release tablets in the treatment of elderly cancer pain patients in China' on Feb. 28.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
Cancer Pain
Intervention:
Group H:D1-14:Patients will adhere to scheduled dosing of extended-release hydromorphone, with rescue medication for breakthrough pain and protocol-defined dose adjustments. Those who develop intolerable study drug-related ...